Stanford inventors have developed a functionally-graded implant device for the reconstitution of the necrotic area removed after surgical treatment of osteonecrosis of the hip.
Stanford inventors have developed a mesenchymal stem cell-based gene therapy that can target the inflammatory environment and secrete immunomodulatory cytokines. The model has been demonstrated in bone marrow mesenchymal stem cells in vitro.